Neoadjuvant chemoradiation for adenocarcinoma of the pancreas.

  title={Neoadjuvant chemoradiation for adenocarcinoma of the pancreas.},
  author={Tara M. Breslin and Nora Anita Janjan and Jeffrey E. Lee and Peter W. T. Pisters and Robert A. Wolff and James L Abbruzzese and Douglas B. Evans},
  journal={Frontiers in bioscience : a journal and virtual library},
Adjuvant 5-fluorouracil and concurrent radiation may improve survival following complete surgical resection in patients with pancreatic adenocarcinoma. However, the morbidity and prolonged recovery associated with pancreaticoduodenectomy frequently prevents the timely delivery of postoperative chemoradiation. Therefore, the University of Texas M.D. Anderson Cancer Center (MDACC) has investigated the use of neoadjuvant chemoradiation in potentially resectable pancreatic cancer. We have… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 27 extracted citations

Similar Papers

Loading similar papers…